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Objectives of the Study. Cleft lip and palate (CLP) is a prevalent congenital anomaly in the orofacial region. Autogenous iliac bone
grafting has been frequently employed for the closure of bone defects at the jaw cleft site. Since the related surgical procedures are
quite invasive for patients, it is of great importance to develop a new less invasive technique. The aim of this study was to examine
bone regeneration with mesenchyme stem cells (MSCs) for the treatment of bone defect in artiﬁcially created jaw cleft in dogs.
Materials and Methods. A bone defect was prepared bilaterally in the upper incisor regions of beagle dogs. MSCs derived from iliac
bone marrow were cultured and transplanted with carbonated hydroxyapatite (CAP) particles into the bone defect area. The bone
regeneration was evaluated by standardized occlusal X-ray examination and histological observation. Results. Six months after the
transplantation, perfect closure of the jaw cleft was achieved on the experimental side. The X-ray and histological examination
revealed that the regenerated bone on the experimental side was almost equivalent to the original bone adjoining the jaw cleft.
Conclusion. It was suggested that the application of MSCs with CAP particles can become a new treatment modality for bone
regeneration for CLP patients.
1.Introduction
Cleft lip and palate (CLP) is a prevalent congenital anomaly
in the orofacial region characterized by a jaw cleft due to
failureofthepalatalshelvestofuseproperly.CLPiscausedby
various genetic and environmental factors, and the incidence
rate of CLP is 0.19% in Japan [1]. Generally, CLP patients
receive labiaplasty and initial palatoplasty at the infant stage
as the initial treatment, and speech therapy is also needed for
the recovery of speech function. In addition, discontinuity of
the upper dental arch due to the jaw cleft frequently causes
malocclusion, and orthodontic treatment is conducted on
most CLP patients for acquisition of stable occlusion.
In 1972, Boyne and Sands [2] reported that smooth
eruption of the canine to the bone transplant area was
induced and excellent dental arch form was obtained by
autogenous iliac bone grafting before canine eruption. Since
then, autogenous iliac bone grafting has been frequently
employed for the closure of bone defects at the jaw cleft site
to establish well-balanced occlusion [3–5].
However, the related surgical procedures to collect trans-
plant material from iliac bone are quite invasive, causing
large stress for the patients. Therefore, artiﬁcial transplant
materials for bone regeneration instead of iliac bone, such as
hydroxyapatite (HAP) and β-tricalcium phosphate (β-TCP),2 International Journal of Dentistry
have been suggested [6, 7]. To date, general clinical appli-
cation of these materials alone has been limited because
of the diﬃculty in induction of canine eruption and tooth
movement to the transplant area [6, 7]. Therefore, it is of
great importance to develop a new less invasive technique.
Tissue engineering with stem cell transplantation is an
expected candidate to achieve osteogenesis in bone defects
with less surgical invasion for ilium extraction. Recently,
stem cells have been applied to regenerative medicine,
even for internal organs such as blood vessels, nerves,
and heart [8–10]. For bone regeneration, mesenchyme
stem cells (MSCs) have been expected to become useful
transplant material. MSCs account for 0.001∼0.01% of the
subcellular component in bone marrow, having the potential
to diﬀerentiate into multiple mesenchyme lineages such as
chondrocytes, adipocytes, and osteoblasts by appropriate
biologicalstimuli[11].Suﬃcientvolumeofbonemarrowfor
separation of MSCs can be aspirated using a bone marrow
puncture needle. The pain score was signiﬁcantly lower
in CLP patients who underwent bone marrow puncture
from iliac bone than in those who underwent conventional
surgical separation of iliac bone marrow, suggesting that the
bone regeneration using MSCs can relieve stress of patients
[12]. However, there have been few studies on osteogenesis
with MSCs in CLP patients [13, 14].
Three elements (cell, scaﬀold, and growth factor) are
believed to be crucial for successful tissue regeneration. In
the present study, we used carbonated hydroxyapatite (CAP)
particles as a scaﬀold. CAP contains 3∼5% carbonate ions
by substitution in the HAP lattice structure and is the
major mineral constituent of bone and teeth. Therefore,
CAP scaﬀold has quite high biocompatibility with the body,
suggesting a big advantage as a scaﬀold material.
In this study, we examined bone regeneration using MSC
transplantation with CAP scaﬀold for artiﬁcial bone defect.
2.MaterialsandMethods
2.1. Preparation of Artiﬁcial Jaw Cleft in Beagle Dogs. Three-
month-old female beagle dogs were used (N = 3). Permission
for a series of experiments in this study was granted by
the Animal Experiment Committee of Hiroshima University.
Brieﬂy, the upper third incisors on both sides were extracted
under general anesthesia (Somnopentyl, Kyoritsu, Tokyo,
Japan). The alveolar and palatal bones were ground by about
5mm in width and 10mm in length to create bilateral
bone defects. The osteoepiphyses were epibolied by suturing
mucosa.Antibiotic(Baytril,BayerHealthCare,Tokyo,Japan)
was used to prevent infection before and after the surgery.
After a 1-month healing period, the artiﬁcial jaw cleft was
evaluatedbyX-rayimagingtocheckwhetherornotthebone
defect was ﬁlled with bone by spontaneous recovery.
2.2. Isolation of MSCs and the Culture. During the healing
period, bone marrow MSCs were isolated from the iliac
bone of each dog and cultured. The bone marrow was
aspirated with a bone marrow puncture needle (Taiyu
MedicalCo.,Tokyo,Japan)fromtheiliacboneofbeagledogs
under general anesthesia with pentobarbital (Somnopentyl,
Kyoritsu). MSCs were seeded at a density of 5 × 105 cells
per 100mm cell-culture dish (Corning, New York, NY, USA)
in Dulbecco’s modiﬁed Eagle’s medium (DMEM, Sigma-
Aldrich, St. Louis, MO, USA) supplemented with 10%
fetal bovine serum (FBS; Biowest, Nuaill´ e, France), 10%
NaHCO3,0 . 7μg/mL L-glutamine, and antibiotics, under 5%
CO2 atmosphere in a humidiﬁed incubator at 37◦C. The
medium was changed every other day, and the MSCs were
subcultureduntilconﬂuence.Thesecond-passagedcellswere
used in all experiments.
2.3. Transplant Body. MSCs were cultured to 1 × 108
cells/well and detached from the culture plates just before
transplantation. Unsintered CAP particles (600–800μm) con-
taining about 10% c a r b o n a t ei o n sw e r eu s e da ss c a ﬀold. One
hundred and eighty mg CAP particles were mixed with MSCs
to allow the cells to attach on the surface of CAP particles.A
transplant consisting of the same volume of CAP particles
without MSCs was used as the control.
2.4. Transplantation of MSCs into Artiﬁcial Jaw Cleft. One
month after the preparation of artiﬁcial jaw cleft, the artiﬁcial
jaw cleft on the both sides was opened under general anesthesia
with pentobarbital (Somnopentyl, Kyoritsu).M S C sw i t hC A P
particles were transplanted into the bone defect on the left
(experimental side), whereas transplant consisting of CAP
particles alone was ﬁlled on the right side cleft (control side).
The bone defect ﬁlled with a transplant was covered with
poly-lactic-co-glycolic-acid (PLGA) barrier membrane (GC
membrane, GC Co., Tokyo, Japan) to prevent leakage of the
transplant. Afterward, mucous membrane was sutured to
intimacy. Antibiotic (Baytril, Bayer HealthCare) was used to
prevent infection before and after the surgery.
2.5.EvaluationofBoneRegenerationbyX-RayImaging. Bone
regeneration was evaluated using standardized occlusal X-
ray images and histological examination. All occlusal X-ray
examinations in this study were standardized using a ﬁlm
holder to maintain positions among X-ray irradiator, object,
and ﬁlm (Figure 1(a)).
The radio-opacity of the artiﬁcial jaw cleft area was
measured using NIH-image 1.59 software (National Insti-
tutes of Health, Bethesda, Washington DC, USA) on the
standardized occlusal X-ray images (Figure 1(b)). The signals
ofregeneratedboneandCAPparticleswereevaluatedbyradio-
opacity of the jaw cleft area.
2.6. Evaluation of Bone Regeneration by Histological Stain-
ing. A small piece of the regenerated tissue was separated
from the dogs under general anesthesia with pentobarbital
(Somnopentyl, Kyoritsu) 3 and 6 months after the transplan-
tation. The tissue specimens were immediately ﬁxed with
4% paraformaldehyde in phosphate-buﬀered saline (PBS)
for5min,decalciﬁedwithEDTAfor1month,andembedded
in paraﬃn. Tissue sections of 7μm thickness were made and
stained with hematoxylin and eosin (HE).International Journal of Dentistry 3
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Figure 1: X-ray examination of bone regeneration (a) Schema of
standardized occlusal X-ray examination. A ﬁlm was held parallel
to the upper dentition of a beagle dog, and X-rays were irradiated
vertically to the ﬁlm at 250mV. The angle and distance between X-
ray bulb and ﬁlm were standardized using a locator. (b) The radio-
opacity without signals of CAP particles in the artiﬁcial jaw cleft
area was measured on standardized occlusal X-ray images.
The number of capillary vessels in the regenerated area
was counted on the tissue sections using a phase contrast
microscope (BZ8000, KEYENCE, Osaka, Japan).
2.7. Statistical Analysis. The transplantation of MSCs was
performed using 3 dogs. Means and standard deviations (SD)
were calculated from the data obtained and then subjected
to Student’s t-test using Graphpad Prism 4.0a software
(Graphpad Software, Inc., San Diego, CA, USA) to examine
signiﬁcant diﬀerences in the means at the 1% and 5% levels
of signiﬁcance.
3. Results
3.1. Intraoral Findings before and after the Transplantation
of MSCs to Artiﬁcial Jaw Cleft. Bilateral artiﬁcial jaw cleft
was prepared on the dog maxilla (Figure 2(a),a r r o w h e a d ) .
The artiﬁcial jaw cleft was opened after 3 months, and no
spontaneous recovery of bone defect was shown. Thus, the
CAP particles with or without MSCs were transplanted to
the bone defects (Figure 2(c), arrowhead). After the trans-
plantation, no inﬂammation was shown in the transplanted
area. Six months after the transplantation, the shape of the
alveolar ridge at the transplanted area was maintained on
both experimental and control sides (Figure 2(d)).
3.2. Radiographic Findings before and after the Transplan-
tation of MSCs to Artiﬁcial Jaw Cleft. No spontaneous
recovery of bone defects was shown by X-ray examination
3 months after the preparation of bilateral artiﬁcial jaw
cleft (Figures 3(a) and 3(b), arrowhead). Immediately after
the transplantation, CAP particles were observed as opaque
regions in images of the jaw cleft (Figure 3(c),a r r o w h e a d ) .
Three months after the transplantation, radio-opacity of
CAPparticleswasreducedonthecontrolsidecomparedwith
that on the experimental side (Figure 3(d), arrowhead), and
decreased more substantially after 6 months (Figure 3(e),
arrowhead).Theradio-opacityontheexperimentalsideafter
6monthswasincreasedwhereasthenumberofCAPparticles
was decreased compared with those at 3 months.
The radio-opacity of CAP particles on the experimental
side was signiﬁcantly ( P<0.05) lower than that on the
control side (Figure 3(f)). On the other hand, the radio-opacity
of regenerated bone on the experimental side was signiﬁcantly
(3 months, P<0.05; 6 months, P<0.01) higher than that on
the control side. These results indicate the digestion of CAP
particlesandcalciﬁcationinthejawcleftontheexperimental
side.
3.3. Histological Observation before and after the Transplan-
tation of MSCs to Artiﬁcial Jaw Cleft. Three and Six months
after the transplantation, the tissues of the transplanted area
were separated and evaluated by histological observation.
Three months after the transplantation, a large number
of CAP particles remained on the control side, whereas only
a few CAP particles were found on the experimental side
on the intraoral photographs (Figures 4(a) and 4(b)). In
addition, the CAP particles had become smaller than the
original particles (600–800μm) on the experimental side.
Histological observation revealed the presence of ﬁbroblastic
cells around CAP particles on the control side (Figures 4(c),
4(d), and 4(e)). On the other hand, no ﬁbroblastic cells were
shown around the CAP particles, and new bone formation
was observed on the experimental side (Figures 4(f), 4(g),
and 4(h)).
Six months after the transplantation, the number of
CAP particles on the control side was decreased but many
particles still remained, whereas almost no CAP particles
were observed on the experimental side (Figures 4(i) and
4(j)). Histological examination revealed that new bone
formation was present locally in the transplanted area on the
control side, but ﬁbroblastic cells were still located around
CAP particles (Figures 4(k), 4(l), and 4(m)). On the other
hand, new bone formation was observed in almost the whole
area on the experimental side, and the CAP particles had
almost disappeared (Figures 4(n) and 4(o)).
The number of capillary vessels was signiﬁcantly (P<
0.01) greater on the experimental side than on the control
side after 3 and 6 months (Figure 5).4 International Journal of Dentistry
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Figure 2: Intraoral ﬁndings before and after the transplantation of MSCs to artiﬁcial jaw cleft. Intraoral images (a) after preparation of
bilateral artiﬁcial jaw cleft in maxilla (arrowhead, jaw cleft), (b) before and (c) after transplantation of MSCs with CAP particles to the
jaw cleft (3 months after the preparation of artiﬁcial jaw cleft). The cleft on the right side (control side) was ﬁlled with CAP particles
alone, whereas the cleft on the left side (experimental side) was ﬁlled with MSCs and CAP particles (arrowhead). (d) 6 months after the
transplantation.
4. Discussion
In the present study, bone regeneration of artiﬁcial jaw
cleft was demonstrated by the transplantation of MSCs
with CAP particles. Radio-opacity of regenerated tissue on
the experimental side was signiﬁcantly higher than that
on the control side, suggesting a contribution of MSCs
to new bone formation. The CAP particles used in the
present study were unsintered, and substituted for 3–5%
carbonate ions in the HAP structure, leading to unstableInternational Journal of Dentistry 5
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Figure 3: Radiographic ﬁndings before and after the transplantation of MSCs to artiﬁcial jaw cleft. Standardized occlusal X-ray images (a)
after preparation of bilateral artiﬁcial jaw cleft in maxilla, (b) before and (c) after transplantation of MSCs with CAP particles to the jaw
cleft (3 months after the preparation of artiﬁcial jaw cleft; arrowhead, jaw cleft). The cleft on the right side (control side) was ﬁlled with
CAP particles alone, whereas the cleft on the left side (experimental side) was ﬁlled with MSCs and CAP particles, (d) 3 months and (e) 6
months after the transplantation (arrowhead, transplanted area). (f) The radio-opacity of the artiﬁcial jaw cleft area was measured on the
standardized occlusal X-ray images after the transplantation to the artiﬁcial jaw cleft. The signals of regenerated bone and CAP particles were
evaluated by radio-opacity of the jaw cleft area. N = 3, ∗P<0.05, ∗∗P<0.01.
crystal structure compared with that of HAP. Since the
solubility of pure HAP is quite low, it would take a long
time to be digested and replaced by n e wb o n ei fu s e df o r
transplantation into bone defect. In a previous study [15],
CAP transplanted above a tooth bud did not disturb tooth
eruption, suggesting its high biocompatibility and solubility
in the body. However, there have been no reports of bone
regeneration in jaw cleft by the use of unsintered CAP
scaﬀold. In our previous study, alveolar bone regeneration
was achieved by transplantation of β-TCP in mouse [6].
However, the scaﬀold for CLP alveolar bone regeneration
requires some special characteristics. The transplantation of6 International Journal of Dentistry
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Figure 4: Histological observation before and after the transplantation of MSCs to artiﬁcial jaw cleft. The regenerated tissues were separated
3 and 6 months after the transplantation. Tissue sections were made and stained with hematoxylin and eosin (HE). Intraoral images 3
months after the transplantation on (a) the control side (CAP alone) and (b) the experimental side (MSCs and CAP particles). The tissue
section showed ﬁbroblastic cells and inﬂammatory cells around CAP particles on the control side (c, d, and e). New bone formation was
shown widely on the experimental side (f, g, and h). Intraoral images 6 months after the transplantation on (i) the control side and (j) the
experimental side. The tissue section showed that new bone formation had occurred locally on the control side (k, l, and m). On the other
hand, new bone formation was observed in almost the whole area on the experimental side (n and o).International Journal of Dentistry 7
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Figure 5: Number of capillary vessels in the regenerated area of
artiﬁcial jaw cleft. Number of Capillary Vessels in Regenerated
Area Was Counted on the Tissue Sections using a Phase Contrast
Microscope. N = 3, ∗∗P<0.01.
β-TCP was suggested to cause disturbance of canine eruption
and tooth movement after its transplantation [6]. Generally,
alignment of tooth on the jaw cleft area by tooth movement
or transplantation is performed after bone regeneration in
the treatment of CLP patients [3, 16]. Therefore, the jaw
cleft should be ﬁlled with bone having normal metabolism
to allow tooth eruption or movement. For this purpose,
transplant material with high solubility in a living body and
that can be digested quickly is considered to be suitable.
Inthepresentstudy,boneregenerationwasaccompanied
by the absorption of CAP particles by the transplantation
of CAP particles and MSCs on the experimental side.
Meanwhile, absorption of CAP particles and new bone
formation were much slower on the control side. In a living
body, osteoclasts and osteoblasts at various diﬀerentiational
phases act as one physiologic unit (basic multicellular unit;
BMU), which controls bone remodeling repeatedly. The
balance of bone absorption and formation is modulated
by BMU activity, and new bone formation is activated
after bone absorption. During the activation phase of bone
remodeling, osteoclasts secrete acid and speciﬁc enzymes for
continuous digestion of bone-salt and bone matrix proteins,
respectively [17]. Therefore, it is speculated that digestion
of transplant material plays a crucial role in new bone
formation, and the diﬀerence in bone regeneration between
the experimental and control sides may be due to the rate of
CAP absorption in this study.
In the present study, the number of capillary vessels
in regenerated tissue after transplantation was signiﬁcantly
greater on the experimental side than on the control side. It
wassuggestedthatMSCsexpressvascularendothelialgrowth
factor (VEGF), which is advantageous for bone regeneration
by inducing vascularization [18]. Since the enhancement of
vascularization is favorable to induce osteoclasts in the bone
regenerationarea,itisassumedthattransplantationofMSCs
may contribute to angiogenesis, leading to enhancement
of CAP digestion by osteoclast induction. The transplan-
tation of MSCs may have relevance for not only their
diﬀerentiation ability into osteoblasts but also for induction
of capillary vessels. If this is true, the transplantation of
undiﬀerentiated MSCs has an advantage compared with the
application of diﬀerentiated MSCs to osteoblasts. However,
it remains unclear whether transplanted MSCs diﬀerentiated
into osteoblasts or just expressed cytokines or growth factors
after transplantation. Tracing of transplanted MSCs would
be beneﬁcial to resolve the above issue in future studies.
In addition, transplanted CAP particles on the control
side were encapsulated with ﬁbroblastic cells, and this may
be another reason for the delay in digestion of CAP particles.
However, it remains unclear why CAP particles on the
experimental side were not encapsulated with ﬁbroblastic
cells.Therefore,themechanismofCAPdigestionshouldalso
be clariﬁed in future studies.
A speciﬁc requirement in bone regeneration of jaw cleft
is the guidance or movement of tooth into newly formed
bone. In this study, suﬃc i e n tv o l u m eo fa l v e o l a rb o n ef o r
tooth movement was formed in the artiﬁcial jaw cleft by the
transplantation of MSCs with CAP particles. Orthodontic
tooth movement is a result of bone remodeling, which has
high relevance to angiogenesis [19]. Since the regenerated
tissue on the control side has a small number of blood vessels
as well as undigested CAP particles, diﬃculty of orthodontic
tooth movement was speculated to be due to low bone
remodeling.
In conclusion, it was shown that the transplantation of
MSCs with CAP particles could regenerate bone in artiﬁcial
jaw cleft. The transplantation of MSCs with CAP particles to
jaw cleft may be a new treatment modality for CLP patients.
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